MedPath

ECHOVIST

ECHOVIST

Discontinued
DIN Number

02237356

Drug Class

Human

Market Date

Feb 15, 1999

Company
HC

berlex canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02237356
AIG Number0236997001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08DA02 MICROPARTICLES OF GALACTOSE
Product Specifications
Dosage FormPowder For Suspension ,  Kit
Route of AdministrationIntrauterine
AHFS Classification92:00.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

GALACTOSEActive
Strength: 3 G / VIAL
Monograph: GALACTOSE
GALACTOSEActive
Strength: 13.5 ML / VIAL
Monograph: GALACTOSE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.